CITIGROUP INC - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 66 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2014. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q2 2019$4,000
-77.8%
7,985
-39.6%
0.00%
Q1 2019$18,000
-14.3%
13,227
-28.4%
0.00%
Q4 2018$21,000
-41.7%
18,477
+41.1%
0.00%
Q3 2018$36,000
-5.3%
13,091
+23.2%
0.00%
Q2 2018$38,000
+15.2%
10,623
-3.2%
0.00%
Q1 2018$33,000
+1000.0%
10,974
+2162.7%
0.00%
Q4 2017$3,000
+200.0%
485
+122.5%
0.00%
Q3 2017$1,000
-50.0%
218
-29.7%
0.00%
Q2 2017$2,000
-90.0%
310
-85.6%
0.00%
Q1 2017$20,000
-86.8%
2,150
-94.3%
0.00%
Q4 2016$152,000
+289.7%
37,972
+272.4%
0.00%
Q3 2016$39,000
-7.1%
10,197
+3.8%
0.00%
Q2 2016$42,000
-73.8%
9,824
-71.6%
0.00%
Q1 2016$160,000
+12.7%
34,555
+143.3%
0.00%
Q4 2015$142,000
+992.3%
14,203
+721.5%
0.00%
Q3 2015$13,000
-93.3%
1,729
-57.4%
0.00%
Q2 2015$193,000
-29.8%
4,063
-45.8%
0.00%
Q1 2015$275,000
-36.3%
7,503
-31.1%
0.00%
Q4 2014$432,000
+980.0%
10,890
+441.5%
0.00%
Q3 2014$40,000
-9.1%
2,011
-38.8%
0.00%
Q2 2014$44,000
+83.3%
3,286
+51.6%
0.00%
Q1 2014$24,000
-63.1%
2,167
-54.9%
0.00%
Q4 2013$65,0004,805
+29931.2%
0.00%
Q3 2013$0
-100.0%
16
-99.2%
0.00%
Q2 2013$14,0002,0050.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q2 2014
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 354,300$7,068,0002.77%
Opaleye Management Inc. 169,700$3,385,515,0002.64%
Broadfin Capital, LLC 959,247$19,137,0002.01%
Novo Holdings A/S 900,000$17,955,0001.75%
Eventide Asset Management 300,900$6,003,0000.84%
EAM Investors, LLC 152,595$3,044,0000.62%
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT 497,858$9,932,0000.51%
Granite Point Capital Management, L.P. 40,000$798,0000.40%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 450,191$8,981,0000.33%
TFS CAPITAL LLC 133,070$2,655,0000.23%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders